Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    June 2021
  1. ORESCHAK K, Saba LM, Rafaels N, Ambardekar AV, et al
    Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.
    J Heart Lung Transplant. 2021 Jun 12. pii: S1053-2498(21)02342.
    PubMed     Abstract available


    May 2021
  2. VIETZEN H, Hartenberger S, Jaksch P, Puchhammer-Stockl E, et al
    Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
    J Heart Lung Transplant. 2021 May 31. pii: S1053-2498(21)02324.
    PubMed     Abstract available


    November 2020
  3. KANWAR MK, Khush KK, Pinney S, Sherman C, et al
    Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
    J Heart Lung Transplant. 2020 Nov 22. pii: S1053-2498(20)31840.
    PubMed     Abstract available


    August 2020
  4. STANKOVIC S, Davey MS, Shaw EM, von Borstel A, et al
    Cytomegalovirus replication is associated with enrichment of distinct gammadelta T cell subsets following lung transplantation: A novel therapeutic approach?
    J Heart Lung Transplant. 2020 Aug 26. pii: S1053-2498(20)31703.
    PubMed     Abstract available


    April 2020
  5. VP RIBEIRO R, Ku T, Ferreira VH, Galasso M, et al
    Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  6. KANWAR M, Pinney S, Shah P, Kobashigawa J, et al
    Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results from the Outcomes Allomap(R) Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  7. STANKOVIC S, Davey MS, Shaw EM, Cristiano Y, et al
    A Potential Role for NKG2C+ gammadelta T Cells as a Cellular Therapy in Combating Post-Lung Transplant Cytomegalovirus Infection.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  8. PIERCE BJ, Pham C, Balk SV, Huang H, et al
    Cytomegalovirus Immune Globulin (CMV-Ig): An Old Drug with Fewer Tricks - Removal of Prophylactic CMV-Ig Administration in CMV Mismatched Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  9. GIFT T, Palafox J, Jones K, Imburgia T, et al
    CMV Viremia after Discontinuation of Valganciclovir Prophylaxis in Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  10. MOSS I, Brueckner A, Rumore A
    Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  11. COUTANCE G, Boutolleau D, Rouvier P, Leprince P, et al
    Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  12. PUING A, Couture-Cosette A, Quintero O, Multani A, et al
    6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  13. CALLAN PD, Yonan N, Santhanakrishnan K, Shaw SM, et al
    Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


    January 2020
  14. POGLAJEN G, Zemljic G, Frljak S, Cerar A, et al
    QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30010.
    PubMed    


    September 2019
  15. HELIOVAARA E, Husain S, Martinu T, Singer LG, et al
    Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes.
    J Heart Lung Transplant. 2019 Sep 10. pii: S1053-2498(19)31672.
    PubMed     Abstract available


    January 2019
  16. MOAYEDI Y, Gomez CA, Fan CPS, Miller RJH, et al
    Infectious complications after heart transplantation in patients screened with gene expression profiling.
    J Heart Lung Transplant. 2019 Jan 7. pii: S1053-2498(19)30006.
    PubMed     Abstract available


    July 2017
  17. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Association between antibody functions and human cytomegalovirus (HCMV) replication after lung transplantation in HCMV-seropositive patients.
    J Heart Lung Transplant. 2017 Jul 18. pii: S1053-2498(17)31901.
    PubMed    


    May 2017
  18. SARMIENTO E, Jaramillo M, Calahorra L, Fernandez-Yanez J, et al
    Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
    J Heart Lung Transplant. 2017;36:529-539.
    PubMed     Abstract available


    August 2016
  19. FORCONI C, Gatault P, Miquelestorena-Standley E, Noble J, et al
    Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    J Heart Lung Transplant. 2016 Aug 26. pii: S1053-2498(16)30295.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: